NCT05640024View on ClinicalTrials.gov

Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors

RecruitingOBSERVATIONAL

Enrollment

54

Participants

Timeline

Start Date

November 6, 2022

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2025

Conditions

Ovarian Cancer

Trial Locations (1)

Unknown

RECRUITING

Yonsei University Health System, Severance Hospital, Seoul

All Listed Sponsors

lead

Yonsei University

OTHER